Abstract
von Willebrand factor (vWF) is a multimeric glycoprotein that promotes platelet aggregation and stabilizes coagulation factor VIII in the plasma. vWF is also required for the stable accumulation of recombinant factor VIII secreted from cells in a heterologous expression system. In this report, we show that vWF can promote the in vitro reconstitution of factor VIII activity from dissociated heavy and light chains of factor VIII, suggesting that vWF may act to promote stable assembly of factor VIII subunits at the site of secretion. The structural requirements for vWF propeptide cleavage and for vWF multimerization in its binding and stabilization of factor VIII was examined using specifically altered recombinant vWF. The mutant vWF molecules were also assayed for their function in ristocetin-induced platelet agglutination mediated through the platelet receptor GPIb. Deletion of the vWF propeptide produced a dimeric vWF molecule that failed to mediate platelet agglutination, suggesting that multimerization is required for vWF to attain functional GPIb binding. This mature dimeric form of vWF, however, was fully capable of binding to and supporting stable secretion of factor VIII. A vWF mutant with an altered propeptide cleavage site formed large multimers of uncleaved pro-vWF that functioned in platelet agglutination. However, this noncleavage mutant neither bound to or supported stable accumulation of factor VIII. Analysis of the vWF propeptide, expressed independently, demonstrated that it could not bind factor VIII or stabilize its secretion. These results show that the dimeric mature vWF subunit is sufficient to bind and stabilize factor VIII and that the presence of uncleaved vWF propeptide inhibits both factor VIII binding and stabilization.
Highlights
VWF, was fully capable of binding to and activation by thrombin (5), recent studies suggest that von Willebrand factor (vWF) supporting stable secretionof factor VIII
Experiments were designed to test the abilityof the vWF immunoprecipitation, factor VI11 activity remaining in the mutantstosupportfactor VI11 accumulation.Serum-free supernatant was determined, and thewashed immunoprecipconditioned medium from each Chinese hamster ovary (CHO) cell line was collected itate pellet was subjectedto gel electrophoresis to identify and and assayed forvWF concentration
A, factor VI11 activity accumu- proposal, we have demonstrated, in aggrement wiath previous lation over 48 h inmedium containing 10% serum (O),serum-free study ( 2 6 ), that vWF can reconstitute factor VI11 activity medium without vWF(X), and serum-freemedium to which purified from isolated subunits in vitro
Summary
Thefactor VI11 complex is composed of a noncovalent association of factor VI11 procoagulant protein (factor VIII) with von Willebrand factor (vWF).’ The factoVrI11 molecule is an important regulator of the blood coagulation cascade. Thefactor VI11 complex is composed of a noncovalent association of factor VI11 procoagulant protein (factor VIII) with von Willebrand factor (vWF).’. The factoVrI11 molecule is an important regulator of the blood coagulation cascade. Factor VI11 cDNA into Chinese hamster ovary (CHO) cells, factorVIII-producing cell lines were established (10). An initial observation was that these factor VIII-producing cells required the presenceof serum for the stable accumulationof factor VI11 activity and that the primary componperonvt ided. Tisement” in accordance wit1h8U.S.C. Section 1734 solely to indicate this fact. $ Present address: Hematology Division, Brigham and Women’s
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.